Covid vax pricing to help govts curb out-of-pocket costs for people: Pfizer
Pfizer has said its Covid-19 vaccine is being priced in a way that will help governments to ensure that there is little to no out-of-pocket costs17-12-2020
17-12-2020
Germany to roll out BioNTech/Pfizer COVID-19 vaccine on December 27
The announcement came as Germany registered its highest daily death toll from COVID-19 and as it entered a strict lockdown in an attempt to bring down soaring infections.17-12-2020
UK vaccinates 137,000 in first week since shot rollout
The Pfizer/BioNTech vaccine was the first coronavirus shot to be authorised for use by the UK's independent medicines regulator. Patients require two doses, 21 days apart.16-12-2020
Canada has deal to get Moderna COVID-19 vaccine within 48 hours of approval
Moderna's vaccine is currently under review by Canada's drug regulator. The Pfizer/BioNTech vaccine received regulatory approval last week and Canada began inoculations on Monday.15-12-2020
US looks to turn tide as Pfizer's Covid-19 vaccine reaches public today
Expects to immunise 100 million people in the first three months of 202114-12-2020
Covid-19 vaccines raise hope for cancer, throw open new field of medicine
Approach used by Moderna. and Pfizer, BioNTech SE partnership have never been used outside of clinical experiments.13-12-2020
Setback for two Covid-19 vaccine candidates; Pfizer nears US approval
Two vaccine candidates stumbled on Friday in the race among researchers to combat Covid-19, even as the Pfizer jab nears approval in the US12-12-2020
Explained | Why DCGI set aside emergency approvals of Serum Institute, Bharat Biotech COVID vaccines
The subject experts committee (SEC) couldn't take up Pfizer's emergency approval request because the US-based drug maker sought more time.09-12-2020
Pfizer-BioNtech COVID vaccine to employ differential pricing for different countries
"The fundamental that went into the pricing was that we make sure we make it very quickly available to everyone," said Pfizer.09-12-2020
Oxford-AstraZeneca vaccine effective, further scrutiny needed among elderly
The Pfizer-BioNTech shot, approved in Britain last week, could be cleared in the U.S. as soon as this week and the European Union by the end of the year as governments race to overcome contagion09-12-2020